ChromaDex Corp. (CDXC) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for ChromaDex Corp. (CDXC:NASDAQ), powered by AI.

Current Price
$3.45
Sector
Healthcare
What is the ChromaDex Corp. stock price forecast?

ChromaDex Corp. is currently trading at $3.45. View real-time AI analysis on Alpha Lenz.

What is ChromaDex Corp. insider trading activity?

View the latest insider trading data for ChromaDex Corp. on Alpha Lenz.

What is ChromaDex Corp.'s P/E ratio?

View ChromaDex Corp.'s valuation metrics on Alpha Lenz.

ChromaDex Corp.

NASDAQ · CDXC
$3.45+0.02(+0.58%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about ChromaDex Corp.'s future dividend policy...
Alpha Chat Insight

ChromaDex Corp.'s ROE is 22.9%. Explore profitability and growth together.

Ask for details

Company Overview

ChromaDex Corp. is a bioscience company that specializes in research, development, and marketing of evidence-based products and ingredients derived from its proprietary technology. The company's primary focus is on the production and commercialization of dietary supplements designed for healthy aging, with a notable product known as Tru Niagen, a supplement aimed at boosting cellular health through its unique nicotinamide riboside chloride formulation. ChromaDex Corp. leverages partnerships with academic and clinical institutions to stay at the forefront of scientific advancements in the field of nutrients and supplements. This strategic approach allows the company to maintain compliance with strict regulatory standards while ensuring the efficacy of its product offerings. By operating within the intersection of health, wellness, and biotechnology, ChromaDex Corp. plays a critical role in the rapidly evolving nutraceutical sector, striving to meet the increasing consumer demand for science-backed health solutions. Its contributions to the market emphasize the potential of biotechnology in enhancing public health and well-being.

CEOMr. Robert N. Fried
SectorHealthcare
IndustryBiotechnology
Employees104

Company Statistics

FY 2024

Profile

N/AMarket Cap
$99.60MRevenue
0.00Shares Out
104Employees

Margins

61.84%Gross
9.25%EBITDA
7.76%Operating
8.89%Pre-Tax
8.58%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

13.87%Rev 3Yr
16.56%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

13.88%ROA
22.94%ROE
12.54%ROIC

Financial Health

$44.51MCash & Cash Equivalents
$-22.32MNet Debt
48.13%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

ChromaDex Corp. (ticker: CDXC) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 104 employees.

The current price is $3.45 with a P/E ratio of -x and P/B of -x.

ROE is 22.94% and operating margin is 7.76%. Annual revenue is $100M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
ChromaDex Corp. (CDXC) Stock Forecast 2026 $3.45 — Price, Financials & Analyst Targets | Alpha Lenz